Cyproterone acetate - indications restricted because of hepatotoxicity and possible carcinogenicity

dc.date.accessioned2016-01-14T09:44:13Z
dc.date.available2016-01-14T09:44:13Z
dc.date.issued1996
dc.identifier.citationThe Ceylon Medical Journal, 41(2)pp.80-81
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/21568
dc.subjectCyproterone acetate
dc.subjectHepatotoxicity
dc.subjectCarcinogenicity
dc.titleCyproterone acetate - indications restricted because of hepatotoxicity and possible carcinogenicity
dc.typeArticle

Files